PMC:2889865 / 3348-3610 16 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1674 | 0-11 | NNS | denotes | lymphocytes |
| T1675 | 12-22 | VBG | denotes | increasing |
| T1676 | 23-28 | NN | denotes | serum |
| T1677 | 29-47 | NN | denotes | cytokine/chemokine |
| T1678 | 48-54 | NNS | denotes | levels |
| T1679 | 54-55 | . | denotes | . |
| T1680 | 56-60 | DT | denotes | This |
| T1681 | 61-66 | VBZ | denotes | forms |
| T1682 | 67-70 | DT | denotes | the |
| T1683 | 71-76 | NN | denotes | basis |
| T1684 | 77-79 | IN | denotes | of |
| T1685 | 80-87 | JJ | denotes | several |
| T1686 | 88-98 | JJ | denotes | autoimmune |
| T1687 | 99-108 | NNS | denotes | disorders |
| T1688 | 109-118 | VBG | denotes | including |
| T1689 | 119-132 | NN | denotes | plasmacytosis |
| T1690 | 133-136 | CC | denotes | and |
| T1691 | 137-148 | NN | denotes | hyperplasia |
| T1692 | 149-150 | NNP | denotes | [ |
| T1693 | 150-152 | CD | denotes | 13 |
| T1694 | 152-153 | NNP | denotes | ] |
| T1695 | 153-154 | . | denotes | . |
| T1696 | 155-157 | TO | denotes | To |
| T1697 | 158-165 | VB | denotes | develop |
| T1698 | 166-172 | JJ | denotes | viable |
| T1699 | 173-178 | NNP | denotes | CXCL8 |
| T1700 | 179-184 | VBN | denotes | based |
| T1701 | 185-194 | NN | denotes | treatment |
| T1702 | 195-205 | NNS | denotes | strategies |
| T1703 | 205-206 | , | denotes | , |
| T1704 | 207-209 | PRP | denotes | it |
| T1705 | 210-212 | VBZ | denotes | is |
| T1706 | 213-222 | JJ | denotes | necessary |
| T1707 | 223-225 | TO | denotes | to |
| T1708 | 226-234 | VB | denotes | identify |
| T1709 | 235-238 | DT | denotes | the |
| T1710 | 239-249 | JJ | denotes | signalling |
| T1711 | 250-258 | NNS | denotes | pathways |
| R1286 | T1676 | T1678 | nmod | serum,levels |
| R1287 | T1677 | T1678 | compound | cytokine/chemokine,levels |
| R1288 | T1678 | T1675 | dobj | levels,increasing |
| R1290 | T1680 | T1681 | nsubj | This,forms |
| R1291 | T1681 | T1681 | ROOT | forms,forms |
| R1292 | T1682 | T1683 | det | the,basis |
| R1293 | T1683 | T1681 | dobj | basis,forms |
| R1294 | T1684 | T1683 | prep | of,basis |
| R1295 | T1685 | T1687 | amod | several,disorders |
| R1296 | T1686 | T1687 | amod | autoimmune,disorders |
| R1297 | T1687 | T1684 | pobj | disorders,of |
| R1298 | T1688 | T1687 | prep | including,disorders |
| R1299 | T1689 | T1688 | pobj | plasmacytosis,including |
| R1300 | T1690 | T1689 | cc | and,plasmacytosis |
| R1301 | T1691 | T1689 | conj | hyperplasia,plasmacytosis |
| R1302 | T1692 | T1694 | quantmod | [,] |
| R1303 | T1693 | T1694 | nummod | 13,] |
| R1304 | T1694 | T1689 | conj | ],plasmacytosis |
| R1305 | T1695 | T1681 | punct | .,forms |
| R1306 | T1696 | T1697 | aux | To,develop |
| R1307 | T1697 | T1705 | advcl | develop,is |
| R1308 | T1698 | T1702 | amod | viable,strategies |
| R1309 | T1699 | T1700 | npadvmod | CXCL8,based |
| R1310 | T1700 | T1702 | amod | based,strategies |
| R1311 | T1701 | T1702 | compound | treatment,strategies |
| R1312 | T1702 | T1697 | dobj | strategies,develop |
| R1313 | T1703 | T1705 | punct | ",",is |
| R1314 | T1704 | T1705 | nsubj | it,is |
| R1315 | T1705 | T1705 | ROOT | is,is |
| R1316 | T1706 | T1705 | acomp | necessary,is |
| R1317 | T1707 | T1708 | aux | to,identify |
| R1318 | T1708 | T1705 | xcomp | identify,is |
| R1319 | T1709 | T1711 | det | the,pathways |
| R1320 | T1710 | T1711 | amod | signalling,pathways |
| R1321 | T1711 | T1708 | dobj | pathways,identify |